Eqalix, Inc. is an emerging  technology development company focused on developing and commercializing products in regenerative medicine for dermatology, cardiovascular applications, and neurology.  Eqalix has licensed several innovative technologies in regenerative medicine, which will revolutionize unmet clinical needs in multiple therapeutic and cosmetic applications. We are initially developing products for consumer and aesthetic dermatology needs in parallel with wound healing applications. For our medium and long-range focus, we plan on developing scientific platforms for regenerative medicine in cardiovascular grafts and three-dimensional tissue scaffolds for neurological repair. For more information, visit www.eqalix.com